Byers Capital is a family office with a focus on early-stage technology investing. We're building and investing in tech and biotech companies.
Announced investments include:
▪ Neuralink (Series B)
▪ NewLimit (Cofounded)
▪ Culdesac (Series A)
▪ Vial (Series A)
▪ Benchling (Growth)
▪ Freenome (Growth)
▪ Grail (Series A)
Byers Capital was founded in 2021 by Blake Byers and is based in San Francisco, CA.
People
- Blake Byers, Founder & Investor
You last contacted this investor on .